TLR-mediated activation of synovial fibroblasts from osteoarthritis patients promotes chondrocyte dysfunction

Toll-like receptors (TLRs) are activated by damage-associated molecular patterns found in cartilage, contributing to osteoarthritis (OA) development. However, the role of synovial fibroblasts in this process is not entirely clear. Researchers examined the TLR responsiveness of human OA synovial fibroblasts and how TLR activation affects fibroblast-mediated regulation of chondrocyte function.

Primary synovial fibroblasts were obtained from OA patients, characterized for TLR expression, and stimulated with agonists targeting TLR1/2 to TLR9. These fibroblasts produced various inflammatory mediators, expressed matrix metalloproteinases, and showed altered mitochondrial respiration when TLRs were activated. Furthermore, TLR1/2, TLR4, TLR5, and TLR2/6 activation led to increased expression of IL-6, IL-8, G-CSF, MMP3, and MMP10.

In contrast, these TLR-activated fibroblasts promoted inflammatory and catabolic gene expression, suppressed anabolic gene expression, and reduced chondrocyte spheroid growth in co-culture. This research reveals that human OA synovial fibroblasts are highly responsive to TLR activation, acquiring a pro-inflammatory and cartilage-degrading phenotype that directly impairs chondrocyte homeostasis.

The findings suggest that targeting shared TLR-mediated pathways in joint-resident cells could serve as a potential disease-modifying therapeutic strategy for OA.